NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Second Sight Medical Products Inc (NASDAQ: EYES)
EYES Technical Analysis
4
As on 30th Aug 2022 EYES STOCK Price closed @ 4.14 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.19 & Strong Sell for SHORT-TERM with Stoploss of 7.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EYESSTOCK Price
Open | 4.34 | Change | Price | % |
High | 4.35 | 1 Day | -0.22 | -5.05 |
Low | 4.14 | 1 Week | -0.21 | -4.83 |
Close | 4.14 | 1 Month | 1.98 | 91.67 |
Volume | 36438 | 1 Year | -10.16 | -71.05 |
52 Week High 14.32 | 52 Week Low 1.16 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
EYES Daily Charts |
EYES Intraday Charts |
Whats New @ Bazaartrend |
EYES Free Analysis |
|
EYES Important Levels Intraday
RESISTANCE | 4.54 |
RESISTANCE | 4.41 |
RESISTANCE | 4.33 |
RESISTANCE | 4.25 |
SUPPORT | 4.03 |
SUPPORT | 3.95 |
SUPPORT | 3.87 |
SUPPORT | 3.74 |
EYES Forecast April 2024
4th UP Forecast | 15.78 |
3rd UP Forecast | 12.05 |
2nd UP Forecast | 9.74 |
1st UP Forecast | 7.43 |
1st DOWN Forecast | 0.85 |
2nd DOWN Forecast | -1.46 |
3rd DOWN Forecast | -3.77 |
4th DOWN Forecast | -7.5 |
EYES Weekly Forecast
4th UP Forecast | 17.24 |
3rd UP Forecast | 13.04 |
2nd UP Forecast | 10.44 |
1st UP Forecast | 7.85 |
1st DOWN Forecast | 0.43 |
2nd DOWN Forecast | -2.16 |
3rd DOWN Forecast | -4.76 |
4th DOWN Forecast | -8.96 |
EYES Forecast2024
4th UP Forecast | 36.53 |
3rd UP Forecast | 26.14 |
2nd UP Forecast | 19.72 |
1st UP Forecast | 13.3 |
1st DOWN Forecast | -5.02 |
2nd DOWN Forecast | -11.44 |
3rd DOWN Forecast | -17.86 |
4th DOWN Forecast | -28.25 |
Second Sight Medical Products Inc ( NASDAQ USA Symbol : EYES )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EYES Other Details
Segment | EQ | |
Market Capital | 106404840.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
EYES Address
EYES Latest News
EYES Business Profile
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California. Address: 13170 Telfair Avenue, Sylmar, CA, United States, 91342
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service